Simparica Trio also contains moxidectin and pyrantel ... These uses are “extra-label” or “off-label,” meaning that there is evidence of safe and effective use, even if FDA approval ...

The product label and all related promotional materials for Simparica Trio have always included information about neurologic signs such as tremors, unsteadiness, and/or seizures that have been ...

The study included dogs that were randomly allocated to one of four treatment groups: Credelio, Simparica TRIO, NexGard or untreated control. Live tick counts were performed on dogs by blinded ...

"The approval of Simparica Trio™ provides veterinarians a safe and effective option for the treatment of external and internal parasitic infestations in dogs in the form of a new oral chewable ...

Zoetis, Inc. ZTS announced that the European Commission (EC) has granted marketing authorization to Simparica Trio (sarolaner/moxidectin/pyrantel) chewable tablets, a once-monthly triple ...